Muñoz JM, Zapién R, Ponce-de-León S, Álvarez JA, Mosqueda JL, Gallaga JC, Macías AE

Language: Spanish
References: 22
Page: 378-382
PDF size: 53.88 Kb.

ABSTRACT

Objective. To determine the rate of contamination of intravenous solutions and injection ports in pediatric patients. Material and methods. During non-epidemic periods, eight pediatric wards in Mexican hospitals were studied. Qualitative cultures were performed from the surface of injection ports and from intravenous solutions in use in pediatric patients younger than 2 years, culturing 750 infusion systems from 728 patients. Results. The rate of contamination of intravenous solutions was 2.4% (18/750; CI 95%: 1.3% to 3.5%) and for injection ports it was 3.2% (24/750; CI 95%: 2.1 % to 4.3%). Enterobacteriaceae predominated; in four cases the organisms isolated from the port and from the solutions were coincident (Klebsiella spp. and Enterobacter sp.). The rate of contamination for solutions mixed in the wards was 5.1%, against 1.3% of those not mixed (χ² = 9.19, p ‹ 0.01). Discussion. Contamination of parenteral solutions is not a rare phenomenon and it could be related to inappropriate practices in the preparation of intravenous solutions and medications as well as the contamination of injection ports. In hospitals working with standards similar to those reported here, the monitoring of sterility of intravenous solutions could contribute to reduce the rate of nosocomial bacteremia.

REFERENCES

1. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16: 778-84.

2. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS, Sanford JP (eds.). Hospital infections. Boston: Little, Brown and Company; 1992, p. 849-92.

3. Maki DG. Nosocomial bacteriemia. Am J Med 1981; 70: 183- 96.

4. Jarvis WR, Cookson ST, Robles B. Prevention of nosocomial bloodstream infections: a national and international priority. Infect Control Hosp Epidemiol 1996; 17: 272-5.

5. Emory TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-42.

6. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusion. J Infect Dis 1975; 131: 267-72.

7. Macias-Hernandez AE, Hernandez-Ramos I, Muñoz-Barrett JM, Vargas-Salado E, Guerrero-Martinez FJ, Medina-Valdovinos H, et al. Pediatric primary Gram-negative nosocomial bacteriemia: a possible relationship with infusate contamination. Infect Control Hosp Epidemiol 1996; 17: 276-80.

8. Pegues DA, Arathoon EG, Samayoa B, et al. Epidemic gramnegative bacteriemia in a neonatal unit in Guatemala. Am J Infect Control 1994; 22: 163-71.

9. Macías AE, Muñoz JM, Herrera LE, Medina H Hernández I, Alcantar D, Ponce de Leon S. Nosocomial pediatric bacteremia. The role of IV set contamination in developing countries. Infect Control Hosp Epidemiol 2004; 25: 226-30.

10. Macías-Hernández AE, Ortega-González P, Muñoz-Barrett JM, et al. Bacteriemia nosocomial pediátrica. El cultivo de soluciones parenterales puede ayudar en su control. Rev Invest Clin 1994; 46: 295-300.

11. Macias AE, Muñoz JM, Bruckner DA, et al. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: Considerations for nosocomial mortality. Am J Infect Control 1999; 27: 285-90.

12. Lwanga SK, Lemeshow S. Sample size determination in health studies. A practical manual. 1st Ed. Geneva: World Health Organization; 1991.

13. Macias AE, Ponce de Leon RS, Huertas M, Maravilla E, Romero C, Montoya TG, Muñoz JM, Lopez-Vidal Y. Endemic infusate contamination and its related bacteremias in a referral hospital with good nursing standards. Am J Infect Control 2008; 36: 48-53.

14. Moore KL, Kainer MA, Badrawi N, et al. Neonatal sepsis in Egypt associated with bacterial contamination of glucosecontaining intravenous fluids. Pediatr Infect Dis J 2005; 24: 590-4.

15. Hernandez-Ramos I, Gaitan-Meza J, Gaitan-Gaitan E, Leon- Ramirez AR, Justiniani-Cedeño N, Avila-Figueroa C. Extrinsic contamination of intravenous infusates administered to hospitalized children in Mexico. Pediatr Infect Dis J 2000; 19: 888-90.

16. Macias AE, Muñoz JM, Galvan A, Gonzalez JA, Medina H, Alpuche C, et al. Nosocomial bacteremia in neonates related to poor standards of care. Ped Infect Dis J 2005; 24: 713-6.

17. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter–related infections. Clin Infect Dis 2002; 35: 1281-307.

18. Macias AE, Bruckner DA, Hindler JA, Muñoz JM, Medina H, Hernandez I, et al. Parenteral infusions as culture media from a viewpoint of nosocomial bacteremia. Rev Invest Clin 2000; 52: 39-43.

19. Ponce de Leon Rosales S, Macias AE. Global perspectives of infection control. In: Wenzel RP. Ed. Prevention and control of nosocomial infections. 4th Ed. Philadelphia: Lippincott Williams and Wilkins; 2003, p. 14-32. ISBN 0-7817-3512-2.

20. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333: 147-54.

21. Crichton EP. Infusion fluids as culture media. Am J Clin Pathol 1973; 59: 199-202.

22. Michaels L, Ruebner B. Growth of bacteria in intravenous infusion fluids. Lancet 1953; 1: 772-4.